Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PTSD Coach as an early mobile intervention to improve cancer-related anxiety and psychosocial oncology uptake in patients newly diagnosed with head and neck cancer: pilot randomized controlled trial.
Ducharme L, Lo C, Hier M, Zeitouni A, Kost K, Mlynarek A, Antoni M, Kuhn E, Owen JE, Heyland D, Platt R, Fuehrmann F, Sadeghi N, Rosberger Z, Frenkiel S, Sultanem K, Shenouda G, Cury F, Henry M. Ducharme L, et al. Among authors: cury f. Pilot Feasibility Stud. 2024 Dec 21;10(1):153. doi: 10.1186/s40814-024-01556-7. Pilot Feasibility Stud. 2024. PMID: 39709459 Free PMC article.
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis.
Marcq G, Kool R, Dragomir A, Kulkarni GS, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Alimohamed N, Izawa J, Jeldres C, Rendon R, Shayegan B, Siemens R, Black PC, Cury FL, Kassouf W. Marcq G, et al. Among authors: cury fl. J Clin Oncol. 2024 Oct 3:JCO2302718. doi: 10.1200/JCO.23.02718. Online ahead of print. J Clin Oncol. 2024. PMID: 39361935
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.
Dahl DM, Rodgers JP, Shipley WU, Michaelson MD, Wu CL, Parker W, Jani AB, Cury FL, Hudes RS, Michalski JM, Hartford AC, Song D, Citrin DE, Karrison TG, Sandler HM, Feng FY, Efstathiou JA. Dahl DM, et al. Among authors: cury fl. J Clin Oncol. 2024 Dec;42(34):4095-4102. doi: 10.1200/JCO.23.02510. Epub 2024 Sep 3. J Clin Oncol. 2024. PMID: 39226514 Clinical Trial.
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer.
Avolio PP, Kool R, Shayegan B, Marcq G, Black PC, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Cury FL, Sanchez-Salas R, Alimohamed N, Izawa J, Jeldres C, Rendon R, Siemens R, Kulkarni GS, Kassouf W. Avolio PP, et al. Among authors: cury fl. Int J Radiat Oncol Biol Phys. 2024 Aug 24:S0360-3016(24)03292-9. doi: 10.1016/j.ijrobp.2024.08.036. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39186955 Free article.
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer.
Halstuch D, Kool R, Marcq G, Breau RH, Black PC, Shayegan B, Kim M, Busca I, Abdi H, Dawidek MT, Uy M, Fervaha G, Cury FL, Alimohamed NS, Jeldres C, Rendon R, Brimo F, Siemens DR, Kulkarni GS, Kassouf W, Izawa JI. Halstuch D, et al. Among authors: cury fl. J Urol. 2024 Nov;212(5):710-719. doi: 10.1097/JU.0000000000004160. Epub 2024 Jul 25. J Urol. 2024. PMID: 39051515
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney.
Tan VS, Correa RJM, Warner A, Ali M, Muacevic A, Ponsky L, Ellis RJ, Lo SS, Onishi H, Swaminath A, Suk Kwon Y, Morgan SC, Cury FL, Teh BS, Mahadevan A, Kaplan ID, Chu W, Hannan R, Staehler M, Zaorsky NG, Louie AV, Siva S. Tan VS, et al. Among authors: cury fl. Eur Urol Oncol. 2024 Dec;7(6):1527-1534. doi: 10.1016/j.euo.2024.06.012. Epub 2024 Jul 9. Eur Urol Oncol. 2024. PMID: 38987159
Genetic Risk For Depression and Quality of Life in Patients With Head and Neck Cancer.
Henry M, Chen LM, Ducharme L, Devault-Tousignant C, Rosberger Z, Frenkiel S, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Chartier G, Mascarella M, Sadeghi N, Sultanem K, Shenouda G, Cury FL, Meaney M. Henry M, et al. Among authors: cury fl. JAMA Otolaryngol Head Neck Surg. 2024 Jul 1;150(7):598-606. doi: 10.1001/jamaoto.2024.0376. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38814668
132 results